Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis

Obesity Surgery

Volumn 19, Issue 5, 2009, Pages 617-624

  Estep, J Michael ^a,b,c   Baranova, Ancha ^a,b,c   Hossain, Noreen ^c   Elariny, Hazem ^c   Ankrah, Kathy ^c   Afendy, Arian ^a,c   Chandhoke, Vikas ^b,c   Younossi, Zobair M ^a,b,c  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b GEORGE MASON UNIVERSITY   (United States)

^c BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

Author keywords

Fibrosis; Morbid obesity; NASH

Indexed keywords

CCL18 CHEMOKINE; CHEMOKINE; CYTOKINE; INTERLEUKIN 10 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5 RECEPTOR ALPHA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FIBROGENESIS; GENE; GENE EXPRESSION; HUMAN; INFLAMMATION; INTRAABDOMINAL FAT; LIVER FIBROSIS; MALE; MICROARRAY ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTRA-ABDOMINAL FAT; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OBESITY, MORBID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RECEPTORS, CYTOKINE;

EID: 67349094003     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-009-9814-x     Document Type: Article

References (26)

1. M Machado H Cortez-Pinto 2005 Non-alcoholic fatty liver disease and insulin resistance Eur J Gastroenterol Hepatol 17 823 826 (Pubitemid 41073319)
2. J Ong H Elariny R Collantes 2005 Predictors of nonalcoholic steatohepatitis and advanced fibrosis in obese patients Obes Surg 15 3 310 315 (Pubitemid 40463594)
3. C Nugent CH Bai H Elariny 2008 Improvement of metabolic syndrome after laparoscopic bariatric surgery Obes Surg 18 10 1278 1286
4. A Baranova SJ Gowder K Schlauch 2006 Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance Obes Surg 16 1118 1125 (Pubitemid 44433145)
5. A Baranova K Schlauch H Elariny 2007 Gene expression patterns in the hepatic tissue and in the visceral adipose tissue of patients with non-alcoholic fatty liver disease Obes Surg 17 8 1111 1118 (Pubitemid 350042936)
6. A Baranova R Collantes K Schlauch 2006 A comparison of serum levels and gene expression of leptin, resistin and adiponectin in the adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance Obes Surg 16 9 1118 1125 (Pubitemid 44433145)
7. YH Lee RE Pratley 2005 The evolving role of inflammation in obesity and the metabolic syndrome Curr Diab Rep 5 70 75 (Pubitemid 40277804)
8. CA Matteoni ZM Younossi T Gramlich 1999 Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1413 1419 (Pubitemid 29258890)
9. G Marchesini M Brizi G Bianchi 2001 Nonalcoholic fatty liver disease. A feature of the metabolic syndrome Diabetes 50 1844 1850 (Pubitemid 33641605)
10. T Gramlich DE Kleiner AJ [tmp] McCullough 2004 Pathologic features associated with fibrosis in non-alcoholic fatty liver disease Human Pathol 35 196 199 (Pubitemid 38240902)
11. N Sasaki T Ueno Y Morita 2006 Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH) Hepatogastroenterology 53 678 681 (Pubitemid 44682981)
12. SG Hubscher 2006 Histological assessment of non-alcoholic fatty liver disease J Clin Gastroenterol 40 S5 S10
13. MD Weltman GC Farrell C Liddle 1996 Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation Gastroenterology 111 1645 1653 (Pubitemid 26404230)
14. A Geerts 2001 History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells Semin Liver Dis 21 3113 3135
15. JN Fain 2006 Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells Vitam Horm 74 443 477
16. T You BJ Nicklas 2006 Chronic inflammation: role of adipose tissue and modulation by weight loss Curr Diabetes Rev 2 29 37 (Pubitemid 44082948)
17. MH Jarrar A Baranova R Collantes 2008 Adipokines and cytokines in non-alcoholic fatty liver disease Aliment Pharmacol Ther 27 412 421
18. A Pradhan 2007 Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose Nutr Rev 65 S152 S156
19. JN Fain AK Madan 2005 Regulation of monocyte chemoattractant protein 1 (mcp-1) release by explants of human visceral adipose tissue Int J Obes (Lond) 29 1299 1307 (Pubitemid 41679260)
20. H Sell J Eckel 2007 Monocyte chemotactic protein-1 and its role in insulin resistance Curr Opin Lipidol 18 258 262 (Pubitemid 46743048)
21. K Kanno S Tazuma T Nishioka 2005 Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression Dig Dis Sci 50 942 948 (Pubitemid 40684916)
22. M Zeyda D Farmer J Todoric 2007 Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production Int J Obes (Lond) 31 1420 1428 (Pubitemid 47339934)
23. F Cipollone F Chiarelli G Davì 2005 Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control Diabetologia 48 1216 1224 (Pubitemid 40909659)
24. SC Afford J Ahmed-Choudhury S Randhawa 2001 CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells FASEB J 15 2345 2354 (Pubitemid 33063163)
25. A Wieckowska BG Papouchado Z Li 2008 Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis Am J Gastroenterol 103 1372 1379
26. L Fontana JC Eagon ME Trujillo 2007 Visceral fat adipokine secretion is associated with systemic inflammation in obese humans Diabetes 56 1010 1013 (Pubitemid 46525079)